pancreatin: prescribing and clinical use
Focused clinical detail for use alongside current product information, local policy and patient-specific assessment.
pancreatin: clinical details
Prescribing considerations
- Confirm pancreatic exocrine insufficiency and individualise the preparation according to age, swallowing ability, food intake and enteral-feeding requirements.
- Review adherence and timing with food before interpreting persistent steatorrhoea, gastrointestinal symptoms or poor nutritional response.
- Record product and batch details where required for traceability of animal-derived biological material.
- Account for the porcine source and discuss relevant allergy, dietary, religious or ethical concerns.
Contraindications and cautions
- Hypersensitivity to pancreatin of porcine origin or any product excipient.
- Pancrex V Powder contains lactose and is unsuitable in specified rare hereditary disorders of galactose metabolism or absorption.
- Investigate unusual or changing abdominal symptoms because fibrosing colonopathy has been associated with high pancreatin exposure, particularly in cystic fibrosis.
- Powder handling can provoke allergic or asthmatic reactions.
Monitoring
- Clinical response, including stool characteristics and gastrointestinal symptoms.
- Weight, growth in children, nutritional status and relevant vitamin or mineral deficiencies.
- Blood glucose where improved carbohydrate absorption may affect diabetes control.
- New or changing abdominal symptoms; consider urate assessment if clinically indicated.
Clinical pharmacology
Porcine lipase, amylase and protease act locally within the gastrointestinal tract. Acid-resistant granules release enzymes in the higher-pH environment of the small intestine; the enzymes are subsequently digested in the gut.
Formulation and product differences
- Creon capsules contain gastro-resistant minimicrospheres and may be swallowed whole or opened for administration with suitable acidic food or liquid.
- Creon Micro consists of gastro-resistant granules designed particularly for infants, children and people requiring a granular formulation.
- Pancrex V Powder is not enteric-coated, contains lactose and can be used orally or through an appropriate nasogastric or gastrostomy tube.
- Products are not automatically interchangeable by capsule, scoop or mass because enzyme activities and pharmaceutical forms differ.
pancreatin preparations and strengths
Capsule
Route: Oral
Strengths: 125 mg, 340 mg
pancreatin interactions
The selected product information reports that formal interaction studies have not been performed. Check other medicines with a pharmacist or prescriber.
Acarbose
Digestive enzyme products may influence acarbose's action; simultaneous administration should be avoided.
Sources
These sources were used to prepare and review this medicine page.
Prepared and reviewed by the iatroX editorial team.